All In Biotech

Free tool

FAERS Monitor: Lamictal Cd

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020764 or its brand name (Lamictal Cd, Lamotrigine). Reports on generic versions are filed under their own applications.

Reports

131,733

Serious

95,211

72% of reports

Hospitalization

40,656

Death reported

11,487

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective10,332
  • rash8,688
  • seizure6,701
  • nausea6,455
  • off label use6,291
  • fatigue6,259
  • dizziness6,075
  • headache5,812
  • depression5,269
  • vomiting4,846
  • somnolence4,541
  • pyrexia4,521
  • drug interaction4,516
  • anxiety4,496
  • toxicity to various agents4,368

Reports by year received

View as table
YearReports
20042,016
20053,052
20063,557
20073,880
20082,377
20094,888
20103,756
20114,923
20125,255
20134,635
20145,128
20157,165
20167,472
20177,202
20188,195
20198,572
20207,702
20217,239
20226,628
20236,979
20247,673
20257,869
20265,569

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,922,426 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal6,7019.89.549,968
drug interactionSignal4,5164.64.512,657
toxicity to various agentsSignal4,3684.24.110,531
depressionSignal5,2693.83.710,545
somnolenceSignal4,5413.73.68,664
rashSignal8,6883.23.213,358
anxietySignal4,4962.52.54,212
pyrexiaSignal4,5212.12.02,615
dizziness6,0752.01.92,873
vomiting4,8461.71.61,263
headache5,8121.51.4938
nausea6,4551.31.3473
fatigue6,2591.31.3409
drug ineffective10,3321.31.2561
off label use6,2911.11.1124

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.